Segall Bryant & Hamill’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.65M | Buy |
68,530
+210
| +0.3% | +$5.49K | 0.02% | 485 |
|
|
2026
Q1 | $1.92M | Hold |
68,320
| – | – | 0.03% | 427 |
|
|
2025
Q4 | $1.7M | Sell |
68,320
-2
| -0% | -$50 | 0.02% | 454 |
|
|
2025
Q3 | $1.74M | Buy |
68,322
+83
| +0.1% | +$2.05K | 0.02% | 449 |
|
|
2025
Q2 | $1.65M | Sell |
68,239
-3,808
| -5% | -$88.8K | 0.02% | 463 |
|
|
2025
Q1 | $1.83M | Sell |
72,047
-4,492
| -6% | -$118K | 0.03% | 444 |
|
|
2024
Q4 | $2.03M | Buy |
76,539
+3,177
| +4% | +$86.2K | 0.03% | 440 |
|
|
2024
Q3 | $2.12M | Buy |
+73,362
| New | +$2.14M | 0.03% | 433 |
|
|
2023
Q4 | – | Sell |
-543,996
| Closed | -$18M | – | 438 |
|
|
2023
Q3 | $18M | Sell |
543,996
-96,821
| -15% | -$3.42M | 0.21% | 132 |
|
|
2023
Q2 | $23.5M | Sell |
640,817
-89,984
| -12% | -$3.5M | 0.25% | 117 |
|
|
2023
Q1 | $29.8M | Sell |
730,801
-6,683
| -0.9% | -$289K | 0.32% | 91 |
|
|
2022
Q4 | $37.8M | Sell |
737,484
-13,616
| -2% | -$653K | 0.42% | 67 |
|
|
2022
Q3 | $32.9M | Sell |
751,100
-8,285
| -1% | -$403K | 0.39% | 72 |
|
|
2022
Q2 | $39.8M | Sell |
759,385
-3,887
| -0.5% | -$198K | 0.45% | 62 |
|
|
2022
Q1 | $39.5M | Sell |
763,272
-11,769
| -2% | -$611K | 0.38% | 77 |
|
|
2021
Q4 | $45.8M | Sell |
775,041
-11,094
| -1% | -$550K | 0.42% | 72 |
|
|
2021
Q3 | $33.8M | Sell |
786,135
-7,143
| -0.9% | -$316K | 0.32% | 91 |
|
|
2021
Q2 | $31.1M | Sell |
793,278
-165,838
| -17% | -$6.45M | 0.3% | 94 |
|
|
2021
Q1 | $34.7M | Sell |
959,116
-42,087
| -4% | -$1.49M | 0.34% | 80 |
|
|
2020
Q4 | $36.8M | Sell |
1,001,203
-74,294
| -7% | -$2.73M | 0.41% | 65 |
|
|
2020
Q3 | $37.5M | Buy |
1,075,497
+22,653
| +2% | +$794K | 0.51% | 57 |
|
|
2020
Q2 | $32.7M | Sell |
1,052,844
-49,908
| -5% | -$1.7M | 0.55% | 52 |
|
|
2020
Q1 | $34.2M | Sell |
1,102,752
-49,052
| -4% | -$1.67M | 0.69% | 40 |
|
|
2019
Q4 | $42.9M | Sell |
1,151,804
-45,225
| -4% | -$1.61M | 0.67% | 40 |
|
|
2019
Q3 | $40.8M | Sell |
1,197,029
-45,337
| -4% | -$1.65M | 0.63% | 42 |
|
|
2019
Q2 | $51M | Sell |
1,242,366
-18,687
| -1% | -$742K | 0.77% | 29 |
|
|
2019
Q1 | $50.8M | Sell |
1,261,053
-13,135
| -1% | -$526K | 0.79% | 23 |
|
|
2018
Q4 | $52.8M | Sell |
1,274,188
-12,492
| -1% | -$519K | 0.91% | 18 |
|
|
2018
Q3 | $53.8M | Sell |
1,286,680
-21,738
| -2% | -$837K | 0.79% | 24 |
|
|
2018
Q2 | $45M | Buy |
1,308,418
+537,171
| +70% | +$18.4M | 0.69% | 31 |
|
|
2018
Q1 | $26M | Sell |
771,247
-5,827
| -0.7% | -$200K | 0.6% | 45 |
|
|
2017
Q4 | $26.7M | Sell |
777,074
-3,226
| -0.4% | -$110K | 0.59% | 50 |
|
|
2017
Q3 | $26.4M | Sell |
780,300
-33,958
| -4% | -$1.09M | 0.61% | 48 |
|
|
2017
Q2 | $25.9M | Sell |
814,258
-8,725
| -1% | -$275K | 0.61% | 45 |
|
|
2017
Q1 | $26.7M | Sell |
822,983
-455
| -0.1% | -$14.3K | 0.65% | 44 |
|
|
2016
Q4 | $25.4M | Sell |
823,438
-5,999
| -0.7% | -$183K | 0.64% | 51 |
|
|
2016
Q3 | $26.7M | Sell |
829,437
-2,763
| -0.3% | -$92.4K | 0.68% | 47 |
|
|
2016
Q2 | $27.8M | Sell |
832,200
-4,688
| -0.6% | -$150K | 0.73% | 41 |
|
|
2016
Q1 | $23.5M | Sell |
836,888
-42,262
| -5% | -$1.21M | 0.58% | 51 |
|
|
2015
Q4 | $26.9M | Buy |
879,150
+1,033
| +0.1% | +$32.5K | 0.65% | 46 |
|
|
2015
Q3 | $26.2M | Buy |
878,117
+66,533
| +8% | +$2.13M | 0.64% | 46 |
|
|
2015
Q2 | $25.8M | Buy |
811,584
+3,783
| +0.5% | +$123K | 0.58% | 51 |
|
|
2015
Q1 | $26.7M | Sell |
807,801
-226
| -0% | -$7.18K | 0.6% | 50 |
|
|
2014
Q4 | $23.9M | Sell |
808,027
-26,401
| -3% | -$757K | 0.54% | 51 |
|
|
2014
Q3 | $23.4M | Buy |
834,428
+8,477
| +1% | +$238K | 0.54% | 58 |
|
|
2014
Q2 | $23.3M | Sell |
825,951
-522,335
| -39% | -$14.9M | 0.55% | 58 |
|
|
2014
Q1 | $41.1M | Sell |
1,348,286
-109,533
| -8% | -$3.27M | 0.98% | 20 |
|
|
2013
Q4 | $42.4M | Buy |
1,457,819
+839
| +0.1% | +$24.4K | 0.99% | 18 |
|
|
2013
Q3 | $39.7M | Buy |
1,456,980
+25,549
| +2% | +$695K | 0.98% | 19 |
|
|
2013
Q2 | $38M | Buy |
+1,431,431
| New | +$39.6M | 1% | 17 |
|
Other funds holding PFE
Segall Bryant & Hamill's PFE Position: Q2 2026 in Review
Segall Bryant & Hamill increased its Pfizer (PFE) stake by 0.31% in Q2 2026, buying an estimated $5.49K and bringing the position to 68,530 shares worth $1.65M. The position accounts for 0.02% of the portfolio, ranked #485.
Segall Bryant & Hamill first reported a position in PFE in Q2 2013 and has held it in 50 quarters since. The position peaked at $53.8M in Q3 2018. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Segall Bryant & Hamill held 68,530 shares of Pfizer worth $1.65M as of Q2 2026.
- Segall Bryant & Hamill bought 210 Pfizer shares in Q2 2026, an estimated $5.49K.
- Pfizer made up 0.02% of Segall Bryant & Hamill's portfolio in Q2 2026, its #485 holding.
- Segall Bryant & Hamill first reported a position in Pfizer in Q2 2013 and has held it in 50 quarters since.
- Segall Bryant & Hamill's Pfizer position peaked at $53.8M in Q3 2018.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.